Sasha Bozeat
Global Medical Science Leader, Roche
Dr Sasha Bozeat is a Global Medical Science Leader at Roche, specializing in the strategic management of external engagements and scientific collaborations within the Alzheimer’s disease therapeutic area. With a career spanning clinical practice, academic research, and the pharmaceutical and diagnostic industries, Sasha brings a multifaceted perspective to the global challenge of neurodegenerative disease.
Sasha holds a degree in Psychology and a PhD in Cognitive Neuropsychology, an academic background that serves as the foundation for her deep expertise in brain health. Her professional journey began in a memory clinic in Cambridge, UK, where she conducted neuropsychological testing. This foundational experience sparked a lifelong interest in the nuances of measuring cognitive function and a dedicated passion for improving the patient journey through timely and accurate diagnosis.
Throughout her career, Sasha has maintained a long-standing interest in the role of education and its significant impact on long-term health outcomes. She leverages this insight and her cross-sector experience to foster high-impact partnerships between industry, academia, and non-governmental organizations (NGOs). Her work is focused on advancing the global standards of diagnosis and management for Alzheimer’s disease, ensuring that scientific innovation translates into meaningful, equitable outcomes for patients and their families worldwide.
The Speakers
Meet the thought leaders and innovators shaping the future of the well-being economy.
Beatrice of York
Founder, By-Eq Limited and Trustee & Co-Founder, The Big Change Charitable Trust
Omar Ben Yedder
Group Publisher and MD, IC Publications
Amanda Xu
Practitioner, OCTAVE Living
Will.i.am
Founder, FYI
Frederic Werner
Chief Strategy and Ops, AI for Good, ITU
Sam Warach
Founder, NextStep Health and Angel Investor
Kaye Vitug
Co-Founder and Co-CEO, Unlocking Eve
Adela Villanueva
Co-Founder and Managing Partner, TIO (The Impact Office)